Author/Authors :
Azarpira Negar نويسنده , Geramizadeh Bita نويسنده , Yaghoobi Ramin نويسنده , Salehi Saeede نويسنده Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran , Zare Mohammad Ali نويسنده , Zarei Neda نويسنده Department of Biotechnology, School of Veterinary
Medicine, Shiraz University, Shiraz, IR Iran , Zare Abdolhossein نويسنده Transplant Research Center, Namazi Hospital, Shiraz
University of Medical Sciences, Shiraz, IR Iran , Zare Mohammad Amin نويسنده School of Electrical and Computer Engineering, Shiraz
University, Shiraz, IR Iran , Malekhosseini Seid Ali نويسنده Transplant Research Center, Namazi Hospital, Shiraz
University of Medical Sciences, Shiraz, IR Iran
Abstract :
Background Discovery of non-invasive methods for acute rejection
in liver transplant patients would contribute to preservation of liver
function in the graft. Recently, however, outcome prediction based on
biostatistical models like artificial neural networks (ANNs) is
increasingly becoming impressive in medicine. Objectives The aim of this
study was to obtain a predictive model based on ANN technique and to
figure out the best time for early prediction of acute allograft
rejection after transplantation in liver transplant recipients. Methods
Feed-forward, back-propagation neural network was developed to predict
acute rejection in liver transplant recipients using clinical and
biochemical data from 148 liver transplant recipients over days 3, 7,
and 14 post-transplantation. Sensitivity and receiver-operating
characteristic (ROC) analysis were done to reveal the importance of
input variables and the performance of the neural network. Results The
results were compared with a logistic regression (LR) model using the
same data. Our results showed that the data related to day 7 gave the
best results in terms of ANN performance; and the most important factors
in the predictive model were aspartate aminotransferase (AST) and
alanine aminotransferase (ALT). The ANN’s accuracy was 90%, sensitivity
was 87%, specificity was 90% in the testing set, and the performance of
the ANN was better than that of the LR model. The ANN recognized
correctly eight out of ten acute rejection patients and 34 out of 36
non-rejection ones in the testing set. Conclusions This study suggests
that ANN could be a valuable adjunct to conventional liver function
tests for monitoring liver transplant recipients in the early
postoperative period.